CLINICAL AND IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA COMBINED WITH TYPE 2 DIABETES MELLITUS
loading.default
item.page.files
item.page.date
item.page.authors
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Web of Journals Publishing
item.page.abstract
The aim of the study was to investigate clinical, laboratory and immunobiochemical markers in patients with bronchial asthma (BA) combined with type 2 diabetes mellitus (T2DM). A comparative analysis of clinical manifestations, carbohydrate metabolism parameters, fibrinolysis and the antioxidant system was performed.